Skip to content
Trial Eligibility
Menu

Dopamine and Sensorimotor Function in Stuttering

NCT07215884

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This study is being done to understand the effect of aripiprazole on adults who stutter. Stuttering is a disorder that affects speech fluency. This study aims to understand sensorimotor pathways of stuttering and possible interventions.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Stuttering, Adult

Eligibility basics and study details

Study type
Interventional
Phase
Phase 1
Ages
18 to 65 years
Sex
All
Healthy volunteers
Accepted
Sponsor
University of California, San Francisco
Last updated on ClinicalTrials.gov
August 19, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • Biomagentic Imaging Lab · San Francisco, CA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.